Suspension of Astrazeneca’s COVID-19 Vaccine Trial in US Continues As FDA Probes Serious Spinal Cord Side – Tech Times

The United States’ Department of Health and Human Services’ agency, Food and Drug Administration (FDA), will conduct its trial that postpones the country’s leg in AstraZeneca’s COVID-19 vaccine trial red flag side effect on a person’s spinal cord. The US FDA will begin to investigate on its own, postponing the trials to midweek.
British biopharmaceutical company, AstraZeneca, recently began its Phase Three Clinical Trials in the United States. Still, after more than just a week, it was halted b…

Click here to view the original article.